Triple
T22693390
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | RNA polymerase II |
E561106
|
entity |
| Predicate | isRegulatedBy |
P1313
|
FINISHED |
| Object | CDK9 kinase |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CDK9 kinase | Statement: [RNA polymerase II, isRegulatedBy, CDK9 kinase]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: CDK9 kinase Context triple: [RNA polymerase II, isRegulatedBy, CDK9 kinase]
-
A.
CDK7 kinase
CDK7 kinase is a cyclin-dependent kinase that functions as a key regulator of transcription initiation and cell cycle control by phosphorylating the C-terminal domain of RNA polymerase II and activating other CDKs.
-
B.
CDK6
CDK6 is a cyclin-dependent kinase that regulates cell cycle progression and is a key target in certain cancer therapies.
-
C.
Cdc28
Cdc28 is the major cyclin-dependent kinase in budding yeast that drives progression through the cell cycle by phosphorylating key regulatory proteins.
-
D.
CDK4
CDK4 is a cyclin-dependent kinase that regulates cell cycle progression and is a key therapeutic target in certain cancers.
-
E.
RET kinase
RET kinase is a receptor tyrosine kinase involved in cell growth and differentiation whose activating alterations drive several cancers, making it an important therapeutic target.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: CDK9 kinase Target entity description: CDK9 kinase is a cyclin-dependent protein kinase that forms part of the P-TEFb complex and promotes transcription elongation by phosphorylating the C-terminal domain of RNA polymerase II.
-
A.
CDK7 kinase
CDK7 kinase is a cyclin-dependent kinase that functions as a key regulator of transcription initiation and cell cycle control by phosphorylating the C-terminal domain of RNA polymerase II and activating other CDKs.
-
B.
CDK6
CDK6 is a cyclin-dependent kinase that regulates cell cycle progression and is a key target in certain cancer therapies.
-
C.
Cdc28
Cdc28 is the major cyclin-dependent kinase in budding yeast that drives progression through the cell cycle by phosphorylating key regulatory proteins.
-
D.
CDK4
CDK4 is a cyclin-dependent kinase that regulates cell cycle progression and is a key therapeutic target in certain cancers.
-
E.
RET kinase
RET kinase is a receptor tyrosine kinase involved in cell growth and differentiation whose activating alterations drive several cancers, making it an important therapeutic target.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454d71b48190a1f80af9f82b6fcf |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1789c6ae481908975b7d27e7624ac |
completed | April 29, 2026, 3:18 a.m. |
Created at: April 17, 2026, 3:13 p.m.